Pesquisas alternativas:
"esto open" » "tests open" (Expandir a Pesquisa), "esto en" (Expandir a Pesquisa), "nest open" (Expandir a Pesquisa)
"oto open" » "two open" (Expandir a Pesquisa)
A mostrar 1 - 20 resultados de 1,014 para a pesquisa '(((("esto open") OR ("esmo open"))) OR ("oto open"))*', tempo de pesquisa: 1.48seg Refinar resultados
Presenting OTO Open
AIOM chooses ESMO Open—Cancer Horizons as its official journal: a warm welcome from ESMO Open

ESMO Open—Cancer Horizons and the future of oncology
CSCO joins ESMO Open—Cancer Horizons

ESMO Open: news in breast cancer 2019
ESMO Open welcomes the association with the Japanese Society of Medical Oncology (JSMO)

ESMO Open special series on new emerging targets in cancer immunotherapy
Announcing the ESMO Open special issue on upcoming molecular targets for cancer treatment

One year of ESMO Open: Cancer Horizons—where are we going from here?
Introducing a new ESMO Open article series: how I treat side effects of immunotherapy

Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion
First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion

CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an ESMO Open—Cancer Horizons pro and con discussion
New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an “ESMO Open – Cancer Horizons” Series

Corrigendum to ‘Clinical significance of ERBB2 exon 16 skipping: analysis of a real-world retrospective observational cohort study’: [ESMO Open Volume 5, Issue 6, 2020, e000985]
Erratum to ‘Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome’: [ESMO Open Volume 6, Issue 1, February 2021, 100005]

Corrigendum to ‘Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)’: [ESMO Open Volume 6, Issue 2, April 2021, 100054]
Does N-acetylcysteine Improve Established Hearing Loss in Guinea Pigs?

Predictors of Professional Fulfillment and Burnout Among Otolaryngologists During the COVID-19 Pandemic
Letter Response: Design and Implementation of a Global Health and Underserved Care Track

Ferramentas de pesquisa: Obter Feed RSS — Enviar pesquisa por email — Guardar a pesquisa